We are pleased to introduce the “Emerging Pharma/Biotech Markets” series of insightful market and technology assessment reports, designed to help Pharmaceutical and Biotechnology industry executives evaluate emerging opportunities and develop successful business expansion strategies. The reports feature latest data, independent analyses, and fresh opinions on industry trends, technologies, products, and market players. - Pharmaceutical M&A in Asia-Pacific: India and China Drive Regional Activity, but Japan
Dominates High Value Transactions - Pharmaceutical Licensing and Alliances in the Asia-Pacific Region - Established and Emerging Biotech Clusters - Emerging Pharmaceutical Markets in Latin America - Opportunities in Emerging Pharma Markets - Emerging R&D Locations - Vaccines in Latin America: Opportunities in Brazil, Mexico and Argentina - HIV in Emerging Markets (Brazil, Russia, India): Growing Need for Second and Third Line
Therapies - Emerging Pharma & Biotech Company Outlook to 2016
|